StreetInsider.com News Articles

BofA names top application software stocks heading into Q3 earnings

Mon, 26 Oct 2026 13:15:31 -0400

Investing.com -- Bank of America analysts highlighted three application software stocks they expect to deliver strong third-quarter results, emphasizing that selectivity has become critical in the sector as artificial intelligence and shifting budget priorities create separation between leaders and laggards.

The firm noted that investor focus remains on growth reacceleration, with increasing preference for application vendors demonstrating successful product cycles and a clear path to monetizing AI opportunities. While AI products are delivering measurable ROI, broader adoption remains constrained by governance, data, trust, and budgets, according to the note.

Bank of America also pointed to general-purpose AI agents from large technology platforms

BofA names top application software stocks heading into Q3 earnings

Mon, 26 Oct 2026 13:15:31 -0400

Bank of America also pointed to general-purpose AI agents from large technology platforms

BofA names top application software stocks heading into Q3 earnings

Mon, 26 Oct 2026 13:15:31 -0400

Bank of America also pointed to general-purpose AI agents from large technology platforms

Hinge Health Inc (HNGE) PT Raised to $130 at Stifel

Sun, 25 Oct 2026 18:32:32 -0400

Stifel analyst David Grossman raised the price target on Hinge Health Inc (NYSE: HNGE) to $130.00 (from $115.00) while maintaining a Buy rating.

The analyst comments "We use SensorTower data to track app downloads and usage of the Hinge Health app (MAUs). September delivered the strongest downloads of 2026, extending August’s rebound and driving a reacceleration in 3Q26 growth. While MAUs declined modestly m/m, the pace of decline moderated significantly and engagement among active users strengthened."

Hinge Health Inc (HNGE) PT Raised to $130 at Stifel

Sun, 25 Oct 2026 18:32:32 -0400

Stifel analyst David Grossman raised the price target on Hinge Health Inc (NYSE: HNGE) to $130.00 (from $115.00) while maintaining a Buy rating.

Hinge Health Inc (HNGE) PT Raised to $130 at BofA Securities

Fri, 23 Oct 2026 05:16:08 -0400

BofA Securities analyst Matt Bullock raised the price target on Hinge Health Inc (NYSE: HNGE) to $130.00 (from $110.00) while maintaining a Buy rating.

Hinge Health Inc (HNGE) PT Raised to $140 at KeyBanc

Fri, 16 Oct 2026 09:11:50 -0400

KeyBanc analyst Scott Schoenhaus raised the price target on Hinge Health Inc (NYSE: HNGE) to $140.00 (from $125.00) while maintaining a Overweight rating.

Form 144 Hinge Health, Inc. Filed by: Insight Venture Partners X (Co-Investors), L.P.

Wed, 14 Oct 2026 18:44:00 -0400

si-local-file:///var/storage/secattach/20261014/27188122.html

Form 144 Hinge Health, Inc. Filed by: Insight Venture Partners (Delaware) X, L.P.

Wed, 14 Oct 2026 18:19:00 -0400

si-local-file:///var/storage/secattach/20261014/27188087.html

Form 144 Hinge Health, Inc. Filed by: Insight Venture Partners X, L.P.

Wed, 14 Oct 2026 17:55:00 -0400

si-local-file:///var/storage/secattach/20261014/27188055.html

Form 144 Hinge Health, Inc. Filed by: Insight Venture Partners (Cayman) X, L.P.

Wed, 14 Oct 2026 17:28:00 -0400

si-local-file:///var/storage/secattach/20261014/27187979.html

Form 4 Hinge Health, Inc. For: Oct 12 Filed by: Budge James

Tue, 13 Oct 2026 17:28:00 -0400

si-local-file:///var/storage/secattach/20261013/27182055.html

Form 4 Hinge Health, Inc. For: Oct 12 Filed by: Mecklenburg Gabriel M.I.

Tue, 13 Oct 2026 17:27:00 -0400

si-local-file:///var/storage/secattach/20261013/27182042.html

Form 144 Hinge Health, Inc. Filed by: Budge James

Tue, 13 Oct 2026 08:20:00 -0400

si-local-file:///var/storage/secattach/20261013/27177683.html

Form 144 Hinge Health, Inc. Filed by: Mecklenburg Gabriel M.I.

Tue, 13 Oct 2026 08:20:00 -0400

si-local-file:///var/storage/secattach/20261013/27177685.html

Hinge Health Inc (HNGE) PT Raised to $110 at Barclays

Mon, 12 Oct 2026 04:30:15 -0400

Barclays analyst Saket Kalia raised the price target on Hinge Health Inc (NYSE: HNGE) to $110.00 (from $100.00) while maintaining a Overweight rating.

Form 4 Hinge Health, Inc. For: Oct 06 Filed by: Perez Daniel Antonio

Wed, 07 Oct 2026 21:58:00 -0400

si-local-file:///var/storage/secattach/20261007/27162364.html

Form 144 Hinge Health, Inc. Filed by: Perez Daniel Antonio

Tue, 06 Oct 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20261006/27155961.html

Form 4 Hinge Health, Inc. For: Oct 05 Filed by: Sloat Tyler

Tue, 06 Oct 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20261006/27155431.html

Hinge Health to announce third quarter 2026 financial results on November 2, 2026

Mon, 05 Oct 2026 12:00:00 -0400

SAN FRANCISCO--(BUSINESS WIRE)-- Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended September 30, 2026, after the U.S. financial markets close on Monday, November 2, 2026.

Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir .hingehealth.com. A replay of the webcast will be

Hinge Health to announce third quarter 2026 financial results on November 2, 2026

Mon, 05 Oct 2026 12:00:00 -0400

Form 4 Hinge Health, Inc. For: Oct 01 Filed by: Pursley James

Thu, 01 Oct 2026 18:49:00 -0400

si-local-file:///var/storage/secattach/20261001/27137582.html

Form 4 Hinge Health, Inc. For: Oct 01 Filed by: Budge James

Thu, 01 Oct 2026 18:48:00 -0400

si-local-file:///var/storage/secattach/20261001/27137580.html

Form 144 Hinge Health, Inc. Filed by: Insight Venture Partners X (Co-Investors), L.P.

Wed, 30 Sep 2026 19:05:00 -0400

si-local-file:///var/storage/secattach/20260930/27129834.html

Form 144 Hinge Health, Inc. Filed by: Insight Venture Partners (Delaware) X, L.P.

Wed, 30 Sep 2026 18:49:00 -0400

si-local-file:///var/storage/secattach/20260930/27129818.html